Results 21 to 30 of about 4,068,473 (311)

Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems. [PDF]

PLoS ONE, 2010
Vascular fibrinolytic balance is maintained primarily by interplay of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1).
John P Bentley, Folkert W Asselbergs, Christopher S Coffey, Patricia R Hebert, Jason H Moore, Hans L Hillege, Wiek H van Gilst   +6 more
doaj   +1 more source

The interaction of drugs to treat cardiovascular diseases and testosterone therapy, their effects and characteristics [PDF]

Journal of Men's Health, 2021
Testosterone is used in the treatment of primary or acquired hypogonadism, constitutional growth retardation, and delayed puberty in male patients. Today, there is a fact that cardiovascular diseases present a high frequency in males with a marked ...
Duygun Altıntaş Aykan, Ahmet Çağrı Aykan   +1 more
doaj   +1 more source

Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease

Frontiers in Cardiovascular Medicine, 2022
Neutrophils and platelets are among the most abundant cell types in peripheral blood and characterized by high plasticity and a readily available reservoir of surface proteins and secretable granule contents.
Rainer Kaiser, Rainer Kaiser, Raphael Escaig, Raphael Escaig, Johanna Erber, Leo Nicolai, Leo Nicolai   +6 more
doaj   +1 more source

Gene-Environment Interactions for Cardiovascular Disease [PDF]

Current Atherosclerosis Reports, 2021
We provide an overview of recent findings with respect to gene-environment (GxE) interactions for cardiovascular disease (CVD) risk and discuss future opportunities for advancing the field.Over the last several years, GxE interactions for CVD have mostly been identified for smoking and coronary artery disease (CAD) or related risk factors.
Jaana A. Hartiala, James R. Hilser, Subarna Biswas, Aldons J. Lusis, Hooman Allayee   +4 more
openaire   +3 more sources

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States

BMC Geriatrics, 2021
Background Polypharmacy continues to be a topic of concern among older adults and puts patients at increased risk of potential drug-drug interactions (DDIs) and negative health outcomes.
Marwan Sheikh-Taha, Myriam Asmar
doaj   +1 more source

Update of the European Association of Cardiovascular Imaging (EACVI) Core Syllabus for the European Cardiovascular Magnetic Resonance Certification Exam. [PDF]

, 2014
An updated version of the European Association of Cardiovascular Imaging (EACVI) Core Syllabus for the European Cardiovascular Magnetic Resonance (CMR) Certification Exam is now available online. The syllabus lists key elements of knowledge in CMR.
Westwood, Mark, Karamitsos, Theodoros T.D., Cosyns, B, Alpendurada, Francisco, Petersen, Steffen Ellebæk, Petersen, SE, Greil, Gerald F., Stefanidis, Alexandros A.S., Bucciarelli-Ducci, C, Karamitsos, TD, Greil, Gerald Franz, Cosyns, Bernard, Lancellotti, Patrizio, Tann, Oliver, Petersen, Steffen E., Stefanidis, Alexandros, Boubertakh, Redha, Karamitsos, Theodoros D., Stefanidis, Alexandros S, Imaging, EAC, Almeida, Ana Gomes, Stefanidis, Alexandros S., Karamitsos, Theodoros D, Stefanidis, AS, Plein, S, Greil, Gerald, Bucciarelli-Ducci, Chiara, Greil, Gerald F, Boubertakh, R, Karamitsos, Theodoros, Westwood, M, Alpendurada, F, ?, ?, Almeida, Ana G, Lancellotti, P, Plein, Sven, Almeida, AG, Greil, GF, Almeida, Ana G., Petersen, Steffen E, Tann, O, Chirinos Medina, Julio, Marwick, Thomas H., Segers, Patrick, Galderisi, Maurizio, Derumeaux, Genevieve, Zamorano, Jose L., Haluska, Brian, Aurigemma, Gerard, Gillebert, Thierry, Tapp, Robyn J., Gottdiener, John, Ofili, Elizabeth, Senior, Roxy   +53 more
core   +1 more source

Drug–Drug–Gene Interactions in Cardiovascular Medicine

Pharmacogenomics and Personalized Medicine, 2022
Innocent G Asiimwe, Munir Pirmohamed The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool ...
Asiimwe IG, Pirmohamed M
doaj  

Multiancestry Study of Gene–Lifestyle Interactions for Cardiovascular Traits in 610 475 Individuals From 124 Cohorts [PDF]

, 2017
Background-Several consortia have pursued genome-wide association studies for identifying novel genetic loci for blood pressure, lipids, hypertension, etc.
Schwander, Karen, Schwander, K, Rao, DC, Cupples, L. Adrienne, Psaty, Bruce M., Borecki, Ingrid, Psaty, BM, Gauderman, W. James, Rao, D. C., Ingrid Borecki, Bruce M. Psaty, Kenneth Rice, L. Adrienne Cupples, Yun J. Sung, Interactions, CHARGEG-L, Rice, Kenneth, Gauderman, J, Borecki, I, Sung, YJ, Thomas W. Winkler, Karen Schwander, Sung, Yun J., Winkler, TW, Cupples, LA, Rice, K, Munroe, Patricia B., Patricia B. Munroe, D. C. Rao, Winkler, Thomas W., W. James Gauderman, Munroe, PB   +30 more
core   +1 more source

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease

Biomedicines, 2022
A comprehensive understanding of gene-diet interactions is necessary to establish proper dietary guidelines to prevent and manage cardio-cerebrovascular disease (CCD).
Sung-Bum Lee, Ja-Eun Choi, Byoungjin Park, Mi-Yeon Cha, Kyung-Won Hong, Dong-Hyuk Jung   +5 more
doaj   +1 more source

Angiotensin-Converting Enzyme Inhibitors and Adipokines: The Role of Visfatin and Apelin in Cardiovascular Disease Management [PDF]

المجلة العراقية للصيدلة, 2023
Background: Angiotensin-converting enzyme (ACE) Inhibitors are medications pivotal in cardiovascular disease management, impacting the renin-angiotensin system which plays a critical role in cardiovascular health. These inhibitors not only modulate blood
Yaseen Jumaah, Zainab Fathi, Jehan Mohammad   +2 more
doaj   +1 more source